Nikko Asset Management Americas’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $117M | Sell |
|
|||||
|
2025
Q1 | $86.3M | Sell |
|
|||||
|
2024
Q4 | $108M | Sell |
|
|||||
|
2024
Q3 | $139M | Sell |
|
|||||
|
2024
Q2 | $170M | Sell |
|
|||||
|
2024
Q1 | $223M | Sell |
|
|||||
|
2023
Q4 | $211M | Sell |
|
|||||
|
2023
Q3 | $157M | Sell |
|
|||||
|
2023
Q2 | $198M | Sell |
|
|||||
|
2023
Q1 | $179M | Sell |
|
|||||
|
2022
Q4 | $163M | Sell |
|
|||||
|
2022
Q3 | $277M | Sell |
|
|||||
|
2022
Q2 | $276M | Sell |
|
|||||
|
2022
Q1 | $291M | Buy |
|
|||||
|
2021
Q4 | $331M | Buy |
|
|||||
|
2021
Q3 | $368M | Sell |
|
|||||
|
2021
Q2 | $548M | Sell |
|
|||||
|
2021
Q1 | $446M | Sell |
|
|||||
|
2020
Q4 | $587M | Buy |
|
|||||
|
2020
Q3 | $309M | Sell |
|
|||||
|
2020
Q2 | $269M | Sell |
|
|||||
|
2020
Q1 | $160M | Buy |
|
|||||
|
2019
Q4 | $186M | Buy |
|
|||||
|
2019
Q3 | $114M | Buy |
|
|||||
|
2019
Q2 | $88.1M | Buy |
|
|||||
|
2019
Q1 | $15.8M | Buy |
|
|||||
|
2018
Q4 | $26K | Sell |
|
|||||
|
2018
Q3 | $50K | Buy |
|